Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stockwatch: Stale M&A And Valuations Limit A Sector Recovery

This article was originally published in Scrip

Executive Summary

Last week the S&P 500 and NASDAQ Biotechnology (NBI) Indexes both finished the shortened trading week up about 1.3%. On the one hand, there's nothing like a long weekend to shift investors' perspective over to the sunny side of the street. On the other, the share prices of life science stocks remain volatile and investment bank analysts are still playing catch-up with downgrades to company share price targets.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC064564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel